JOANNE GALINDO: Open Payments
NPI 1013648203 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,402 in 92 payments from 20 companies in 2025. Trend: 2023 $2,482 · 2024 $1,661 · 2025 $1,402
Food & beverage: $1,402
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 22 | $275 |
| Novo Nordisk Inc | 12 | $171 |
| Axsome Therapeutics, Inc. | 13 | $155 |
| Lilly USA, LLC | 12 | $127 |
| Verity Pharmaceuticals Inc. | 3 | $93 |
| Otsuka America Pharmaceutical, Inc. | 4 | $84 |
| ABBVIE INC. | 4 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $76 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Xeris Pharmaceuticals, Inc. | 2 | $46 |
Products named: MOUNJARO, ZAVZPRET, NURTEC ODT, Tlando, REXULTI, Sunosi, Auvelity, Ozempic.
Industry payments across CA — which companies pay providers there.
